The Cardiovascular Research Foundation (CRF) announced that TVT: The Structural Heart Summit will feature 12 studies as Late-Breaking Clinical Science and Featured Clinical Research. An annual meeting covering cutting-edge research and techniques for structural heart interventions, TVT will take place June 8-10, 2022, at the Sheraton Grand Chicago Riverwalk in Chicago, Illinois.
The more antibiotics prescribed to patients 60 and older, the more likely they were to develop inflammatory bowel disease, suggesting antibiotic use could explain some of the growth in Crohn’s disease and ulcerative colitis in older people, according to a review of 2.3 million patient records in a study selected for presentation at Digestive Disease Week® (DDW) 2022.
Hispanic people who went to the emergency room (ER) reporting chest pain waited longer than non-Hispanic people to be treated, admitted to the hospital or discharged from the ER, according to preliminary research to be presented at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2022.
Public Health conference hosted by Temple University Rome and Temple College of Public Health.
Cedars-Sinai geriatrics experts will present their latest advances in research and care in person at the annual scientific meeting of the American Geriatrics Society (AGS) in Orlando May 12-14, sharing innovations to improve both the quality of patient care and quality of life for older adults.
The new WHO European Regional Obesity Report 2022, published on 3 May by the WHO Regional Office for Europe, reveals that overweight and obesity rates have reached epidemic proportions across the Region and are still escalating, with none of the 53 Member States of the Region currently on track to meet the WHO Global Noncommunicable Disease (NCD) target of halting the rise of obesity by 2025.
Get the latest insights from leading nutrition scientists and practitioners at NUTRITION 2022 LIVE ONLINE, the flagship online meeting of the American Society for Nutrition. Explore the meeting program for scientific sessions, special events and featured speakers.
This year marks 50 years since it came to light that the nation’s leading public health agency, the Public Health Service, conceived an unethical “research study” - the Tuskegee Experiment – that lasted for 40 years. The participants? Black men in a rural community in the South who existed in a state of quasi-slavery, making them extremely vulnerable and the agency’s treatment of them that much more sickening.
Single-lead ECG tracings from an Apple Watch interpreted by an artificial intelligence (AI) algorithm developed at Mayo Clinic effectively identified patients with a weak heart pump.
Several nursing teams from Roswell Park Comprehensive Cancer Center were invited to share their research at the 47th Annual Congress of the Oncology Nursing Society (ONS), which is underway in Anaheim, California, and continues through May 1, 2022.
UC San Diego researchers developed a smartphone app that could allow people to screen for Alzheimer's disease, ADHD and other neurological diseases and disorders—by recording closeups of their eye. The app uses a smartphone's built-in near-infrared camera and selfie camera to track how a person's pupil changes in size. These pupil measurements could be used to assess a person's cognitive condition.
Six in ten people with COVID-19 still have at least one symptom a year later, a new study being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal (23-26 April) has found.
Oncology Nurses from Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health will be presenting at the Oncology Nursing Society’s (ONS) 47th Annual Congress being held April 27 to May 1 in Anaheim, California.
ISPOR—The Professional Society for Health Economics and Outcomes Research announced that its annual international conference, ISPOR 2022, is offering a Real-World Evidence Subprogram May 15-18.
oswell Park Comprehensive Cancer Center specialists will share the latest advances and developments in the treatment of blood-related cancers at the 2022 Tandem Transplantation & Cellular Therapy Meetings of American Society for Transplantation and Cellular Therapy (ASTCT) and Center for International Blood and Marrow Transplant Research (CIBMTR) in Salt Lake City, Utah, from April 23 to 26.
The longest known COVID-19 infection is described by UK researchers at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April).
The average number of global deaths from COVID-19 were 6% higher on weekends compared to weekdays (8,532 vs 8,083) throughout the pandemic, according to new research analysing all deaths reported to the WHO COVID-19 database between March 7, 2020 and March 7, 2022.
Study of 853 counties in Minas Gerais state finds counties that voted for Brazilian President Jair Bolsonaro in the 2018 election are more likely to have higher incidence and death rates from COVID-19
NUTRITION 2022 LIVE ONLINE is your source for the latest in nutrition science. Join us June 14-16, 2022, to explore the latest developments in nutrition science, clinical topics and policy issues through lectures, scientific sessions, virtual abstract presentations and more. Get a sneak peek at the meeting program today!
APS’s 34th annual gathering will feature leading psychological researchers presenting on virtually all aspects of human behavior, including substance abuse and addiction, sexual and emotional health, mental health and depression, COVID-related research, and the impact of misinformation and how to fight it.
CoVac-1, a new vaccine against SARS-CoV-2, induced T-cell immune responses in 93 percent of patients with B-cell deficiencies, including many patients with leukemia and lymphoma, according to results presented at the AACR Annual Meeting 2022, held April 8-13.
A new drug has proven beneficial in treating a movement disorder commonly associated with Huntington’s disease, according to a recent international study led by UTHealth Houston researcher Erin Furr Stimming, MD, who served as principal investigator on behalf of the KINECT-HD Huntington Study Group.
Researchers have developed a new computational tool to select optimal combination therapies for patients with cancer based on the co-occurring alterations in a given tumor.
The ATS 2022 International Conference is coming back strong! Whether you cover clinical medicine or research, the programming at ATS 2022 is an extensive roundup of the latest in pulmonary, critical care and sleep medicine.
ISPOR announced its plenary sessions and speakers for its annual international conference, ISPOR 2022. The conference will be held May 15-18.
Combination immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab and other novel agents outperforms durvalumab alone in the neoadjuvant (pre-surgical) setting for early-stage non-small-cell lung cancer.
Adding the immunotherapy drug nivolumab to chemotherapy before surgery (neoadjuvant) for patients with operable non-small cell lung cancer (NSCLC) reduced the risk of recurrence of the cancer or death by more than one-third, according to results from the phase III CheckMate-816 trial.
Data from the National Health Interview Survey demonstrated adults with a history of allergic disorders have an increased risk of high blood pressure and coronary heart disease, with the highest risk seen in Black male adults.
New data from MD Anderson-led studies on ATR inhibitor and next-generation PARP1 inhibitor presented at AACR Annual Meeting
New data to be presented by Grace Dy, MD, at the American Association for Cancer Research Annual Meeting show that patients with non-small cell lung cancer (NSCLC) who received the targeted therapy sotorasib experienced extended survival and good quality of life.
Researchers from The University of Texas MD Anderson Cancer Center showed that natural killer (NK) cells derived from donated umbilical cord blood, combined with a novel bispecific antibody known as AFM13 that targets CD16A and CD30, achieved effective responses in patients with pretreated and refractory CD30+ lymphoma. The study was presented today at the American Association for Cancer Research (AACR) Annual Meeting 2022.
Combining a beta-blocker with the cancer immunotherapy drug pembrolizumab could be a promising new treatment option for many hard-to-treat solid-tumor cancers. Researchers from Roswell Park Comprehensive Cancer Center will report on a study of of this treatment combination in patients with advanced or metastatic melanoma at the American Association for Cancer Research (AACR) Annual Meeting 2022.
Two Roswell Park Comprehensive Cancer Center oncologists will discuss promising strategies for making breakthrough immunotherapies work for more patients at the annual meeting of the American Association for Cancer Research (AACR) in New Orleans, Louisiana, on Monday, April 11.
This special edition features presentations by MD Anderson researchers at the AACR Annual Meeting 2022, including early-stage clinical trials on immunotherapy and targeted therapies plus laboratory studies to improve immunotherapy responses, to understand early lung cancer development, to clarify the role of ZEB1 in lung cancer metastasis and to develop new treatments for cancers with KRAS mutations.
Smoking cessation adds the same number of heart disease-free years to life as three preventive medications combined, according to research presented at ESC Preventive Cardiology 2022, a scientific congress of the European Society of Cardiology (ESC).1
SEATTLE — April 6, 2022 — Below are summaries of recent Fred Hutchinson Cancer Research Center research findings and other news. If you’re covering the American Association of Cancer Research’s annual meeting, April 8-13, see our list of Fred Hutch highlights for AACR and contact [email protected] for help setting up interviews with experts.
Dozens of cancer specialists at Roswell Park Comprehensive Cancer Center have been invited to present their latest advances in cancer research at the annual meeting of the American Association for Cancer Research (AACR), which will take place in New Orleans, Louisiana, from April 8 to 13.
A new study by researchers at Intermountain Healthcare in Salt Lake City finds that alcohol consumption does not provide additional heart benefits in cardiology patients already being treated with statins – the most commonly used drugs to lower cholesterol.
Results from a new study suggest that two sugar substitutes disrupt the function of a protein that plays a vital role in liver detoxification and the metabolism of certain drugs. These sugar substitutes, also known as non-nutritive sweeteners, provide a sweet taste with few or no calories.
Findings from a new study are providing important insights into the spread of Rocky Mountain spotted fever, which is transmitted from dogs to people through ticks. The new data are being used to create models that could help predict, and possibly prevent, future outbreaks.
In a new study conducted in rats, scientists report evidence that vitamin K could help protect against aging-related cognitive declines associated with Alzheimer’s disease and other forms of dementia.
In a new study, many athletes reported symptoms that are often used to diagnose concussions even though they did not suffer a head injury. The findings suggest that some symptoms, such as fatigue and neck pain, could be attributed to intense exercise rather than a brain injury.
The tool being used to diagnose concussions might be overestimating the condition and wrongly identifying symptoms like fatigue and neck pain caused from intense exercise and not a brain injury, according to Rutgers researchers. This new research raises new questions about the Sport Concussion Assessment Tool (SCAT), a questionnaire widely used along with other methods to diagnose concussions sustained during sports. Findings were presented at the American Physiological Society annual meeting April 5.
Almost half of the U.S. adult population has high blood pressure — or hypertension — and about 20% of these patients have treatment-resistant hypertension. The reason why some people are resistant to treatment has been a mystery, but new study results show that a certain gut bacterium may be an important factor.
A new study using prenatal brain scans revealed significant differences in brain structures at around 25 weeks’ gestation between children who were later diagnosed with ASD and those who were not. The study adds to mounting evidence that autism begins in early development and suggests possible opportunities to identify the disorder at an earlier age.
Researchers have identified a family of proteins that is significantly elevated in the saliva of patients hospitalized with COVID-19. The proteins, known as ephrin ligands, could potentially serve as a biomarker to help doctors identify patients who are at risk for serious illness.
A simple blood test for women of all ages and risk levels could one day be possible thanks to a new set of protein biomarkers that researchers identified using breast milk.
A study conducted in rats suggests that taking vitamin C may help to counteract the muscle atrophy that is a common side effect of the chemotherapy drug doxorubicin. Although clinical studies would be needed to determine the safety and effectiveness of taking vitamin C during doxorubicin treatment, the findings suggest vitamin C may represent a promising opportunity to reduce some of the drug’s most debilitating side effects.
Findings from a new animal study suggest that cannabidiol (CBD) and tetrahydrocannabinol (THC) might be safe for use with opioid pain relievers. Although more studies are needed, the results suggest that these compounds might be a low-risk way to reduce the dose of opioids needed to relieve pain.
A new animal study has provided important insights into how COVID-19 SARS-CoV-2 — the virus responsible for COVID-19 — can lead to long-term pain. The new findings also point to a potential therapy for COVID-related pain.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right